FINHUB Insights

DVA · Q2 FY26 · Apr 1 – Jun 30, 2026

DaVita Q2 FY26: where the revenue came from and where it went

DaVita Q2 FY26: revenue $3.6B (+5% year over year). Net profit $0.27B. Largest cohort U.S.Dialysis & related lab $3.0B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Aug 4, 2026 10-Q
Sankey diagram of DaVita's income statement for Q2 FY26: revenue of $3.55 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.55B +5% year over year
Gross profit$1.00B 28% margin
Operating profit$0.58B 16% margin
Net profit$0.27B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 3.55 100% +5%
U.S.Dialysis & related lab 3.00 84% +4%
All other 0.55 16% +15%
Cost of revenue−2.5572%
Gross profit1.0028% margin+0pp
G&A−0.4212%+0pp
Operating profit0.5816% margin+0pp
Tax−0.09
Interest & other costs−0.22
Net profit0.277%+2pp
Filing on EDGAR More quarters of DVA

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.